Trial Profile
A retrospective study to evaluate the use of eltrombopag after romiplostim in primary immune thrombocytopenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2016
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary) ; Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 08 Dec 2015 New trial record